<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4--><!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
   <PublisherInfo>
      <PublisherName>Springer-Verlag</PublisherName>
      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
   </PublisherInfo>
   <Journal>
      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">
         <JournalID>401</JournalID>
         <JournalPrintISSN>0001-6322</JournalPrintISSN>
         <JournalElectronicISSN>1432-0533</JournalElectronicISSN>
         <JournalSPIN/>
         <JournalTitle>Acta Neuropathologica</JournalTitle>
         <JournalSubTitle/>
         <JournalAbbreviatedTitle>Acta Neuropathol</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Legacy</JournalSubject>
</JournalSubjectGroup>
      </JournalInfo>
      <Volume>
         <VolumeInfo VolumeType="Regular">
<VolumeIDStart>101</VolumeIDStart>
<VolumeIDEnd>101</VolumeIDEnd>
<VolumeIssueCount/>
</VolumeInfo>
         <Issue IssueType="Regular">
            <IssueInfo TocLevels="0">
               <IssueIDStart>6</IssueIDStart>
               <IssueIDEnd>6</IssueIDEnd>
               <IssueHistory>
                  <OnlineDate>
                     <Year>2001</Year>
                     <Month>6</Month>
                     <Day>13</Day>
                  </OnlineDate>
                  <PrintDate>
                     <Year>2001</Year>
                     <Month>6</Month>
                     <Day/>
                  </PrintDate>
                  <CoverDate>
                     <Year>2001</Year>
                     <Month>6</Month>
                  </CoverDate>
               </IssueHistory>
               <IssueCopyright>
                  <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                  <CopyrightYear>2001</CopyrightYear>
               </IssueCopyright>
            </IssueInfo>
            <Article ID="Art1">
               <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
                  <ArticleID>00332</ArticleID>
                  <ArticleDOI>10.1007/s004010000332</ArticleDOI>
                  <ArticleTitle Language="En">Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells</ArticleTitle>
                  <ArticleCategory>Regular Paper</ArticleCategory>
                  <ArticleFirstPage>605</ArticleFirstPage>
                  <ArticleLastPage>615</ArticleLastPage>
                  <ArticleHistory>
                     <Received>
                        <Year>2000</Year>
                        <Month>08</Month>
                        <Day>18</Day>
                     </Received>
                  </ArticleHistory>
                  <ArticleCopyright>
                     <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                     <CopyrightYear>2001</CopyrightYear>
                  </ArticleCopyright>
<ArticleGrants>
<MetadataGrant Grant="OpenAccess"/>
<AbstractGrant Grant="OpenAccess"/>
<BodyPDFGrant Grant="Restricted"/>
<BodyHTMLGrant Grant="Restricted"/>
<BibliographyGrant Grant="Restricted"/>
<ESMGrant Grant="Restricted"/>
</ArticleGrants>
               </ArticleInfo>
               <ArticleHeader>
                  <AuthorGroup>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Christopher</GivenName>
                           <FamilyName>Thomas</FamilyName>
                        </AuthorName>
                        <Contact>
                           <Phone>+1-904-9537293</Phone>
                           <Fax>+1-904-9532315</Fax>
                           <Email>thomc6@mayo.edu</Email>
                        </Contact>
                     </Author>
                     <Author AffiliationIDS="A4">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Greg</GivenName>
                           <FamilyName>Ely</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A4">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>David</GivenName>
                           <GivenName>C.</GivenName>
                           <FamilyName>James</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A4">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Robert</GivenName>
                           <FamilyName>Jenkins</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A3">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Michael</GivenName>
                           <FamilyName>Kastan</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A5">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Anne</GivenName>
                           <FamilyName>Jedlicka</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A5">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Peter</GivenName>
                           <FamilyName>Burger</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A2">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Robert</GivenName>
                           <FamilyName>Wharen</FamilyName>
                        </AuthorName>
                     </Author>
                     <Affiliation ID="A1">
                        <OrgName>Mayo Clinic-Jacksonville, Mayo Medical School, Division of Hematology/Oncology, Davis E8A Oncology, 4500 San Pablo Road, Jacksonville, FL 32224, USA</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A2">
                        <OrgName>Mayo Clinic-Jacksonville, Mayo Medical School, Department of Neurosurgery, Jacksonville, Florida, USA</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A3">
                        <OrgName>The Johns Hopkins School of Medicine, Oncology Center, Baltimore, Maryland, USA</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A4">
                        <OrgName>Department of Experimental Pathology, Mayo Clinic, Rochester, Minnesota, USA</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A5">
                        <OrgName>Departments of Pathology and Oncology, Johns Hopkins Medical School, Baltimore, Maryland, USA</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A6">
                        <OrgName>Present address: Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                  </AuthorGroup>
                  <Abstract ID="Abs1" Language="En">
                     <Heading>Abstract.</Heading>
                     <Para> Amplification of the epidermal growth factor receptor (EGFR) gene is found in about 40% of glioblastomas (GBMs) but is rarely detected in GBM cell lines. We confirmed that the exceptional SKMG-3 GBM cell line retained amplified EGFR genes in vitro, and found that these sequences were concentrated on extra-chromosomal DNA particles similar to double-minute chromosomes. The cells contained two other gene mutations that are associated with high-grade astrocytic tumors: extra-chromosomal amplification of the cyclin-dependent kinase-4 (CDK4) gene and a homozygous mutation within the PTEN tumor suppressor gene. Immunoblots revealed very high levels of EGFR, moderately increased expression of CDK4, and no detectable PTEN protein. The over-expressed SKMG-3 EGFRs responded to exogenous ligand and resembled normal rather than mutant receptors. A heterozygous mutation of the p53 gene (p53<Superscript>R282W</Superscript>) correlated with failure of radiation to induce the expression of cyclin-dependent kinase inhibitor p21<Superscript>waf1</Superscript> or an early G1 cell cycle arrest. Although each of these gene mutations occurs in GBMs, SKMG-3 cells had an unusual genotype in that a p53 gene mutation co-existed with amplified EGFR genes. Nonetheless, the SKMG-3 cell line can be exploited as a model to study how oncogenic EGFR signals in GBM cells interact with over-expressed CDK4 and loss of PTEN to confer the malignant phenotype.</Para>
                  </Abstract>
                  <KeywordGroup Language="En">
                     <Keyword>Glioblastoma Tumor cells Epidermal growth factor receptor p53 gene PTEN</Keyword>
                  </KeywordGroup>
                  <ArticleNote Type="Misc">
                     <SimplePara>Revised, accepted: 19 October 2000</SimplePara>
                  </ArticleNote>
                  <ArticleNote Type="Misc">
                     <SimplePara>Electronic Publication</SimplePara>
                  </ArticleNote>
               </ArticleHeader>
               <BodyRef FileRef="BodyRef/PDF/401_2001_Article_332.pdf" TargetType="PDF"/>
            </Article>
         </Issue>
      </Volume>
   </Journal>
</Publisher>